SLNO SOLENO THERAPEUTICS INC

BEARISH Impact: 8/10 15-12G
Horizon immediate Filed May 28, 2026 Processed 9d 7h ago SEC 0001193125-26-245197
Deregistration

Price Chart

Loading chart...

Executive Summary

Soleno Therapeutics filed Form 15-12G to terminate its SEC registration under Section 12(g) and suspend reporting obligations, effective immediately. The filing states only one holder of record remains, and a Form 25-NSE was filed 10 days prior to delist from Nasdaq. This marks a complete exit from public markets — shareholders lose all SEC reporting transparency and liquidity, with shares likely moving to the OTC markets.

Actionable Insight

With Nasdaq delisting already initiated and SEC deregistration now effective, SLNO common stock will trade on OTC markets with minimal transparency. Existing shareholders face severe liquidity degradation and no ongoing financial disclosures. Traders should expect wide bid-ask spreads and potential for further price declines as institutional holders exit. No recovery catalyst is visible — this is a terminal public market exit absent a buyout.

Key Facts

  • Form 15-12G filed to terminate registration under Section 12(g) and suspend Section 13/15(d) reporting duties
  • Only one holder of record remains as of certification date (May 28, 2026)
  • Form 25-NSE filed 10 days earlier (May 18, 2026) to delist from Nasdaq
  • Company was formerly known as Capnia, Inc. (name change 2010)
  • President and Secretary Darin M. Lippoldt signed the filing

Financial Impact

Complete loss of public market liquidity and SEC reporting — no financial figures available in filing

liquidityshareholder basepublic reporting status

Risk Factors

  • OTC trading will have severely reduced liquidity and wider spreads
  • No future SEC filings means zero transparency on financials or operations
  • Potential acceleration of stock price decline as remaining holders exit

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (16 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
15-12G Filing (Primary)0001193125-26-245197
Document: 0001193125-26-245197-index-headers.html0001193125-26-245197
Document: 0001193125-26-245197-index.html0001193125-26-245197
Document: 0001193125-26-245197.txt0001193125-26-245197
8 reports for SLNO
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+60▲ +29.26%Feb 25, 2026
Filters
Rows
Reports for SLNO — sortable, filterable
Type Now
May 28, 2026
9d ago
15-12G
BEARISH ★ 8/10
awaiting T+1
May 28, 2026
9d ago
EFFECT
BEARISH ★ 5/10
awaiting T+1
May 18, 2026
19d ago
8-K / 25-NSE
BULLISH ★ 8/10
$53.01 $53.01· 0.00%▲ +0.65%
Apr 7, 2026
8w ago
8-K
BEARISH ★ 7/10
$52.35 $52.60▼ −0.48%▲ +2.06%
Apr 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$52.25 $52.35▲ +0.19%▲ +0.13%
Mar 27, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$30.05 $30.44▲ +1.30%▲ +1.66%
Feb 26, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$38.09 $39.07▲ +2.57%▲ +3.03%
Feb 25, 2026
14w ago
8-K
BULLISH ★ 8/10
$41.01 $38.09▼ −7.12%▼ −6.57%
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (33h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access